{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T21:37:27Z","timestamp":1773697047566,"version":"3.50.1"},"reference-count":0,"publisher":"Oxford University Press (OUP)","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,10,15]]},"DOI":"10.1053\/euhj.2002.3173","type":"journal-article","created":{"date-parts":[[2002,9,25]],"date-time":"2002-09-25T22:29:09Z","timestamp":1032992949000},"page":"1575-1579","source":"Crossref","is-referenced-by-count":6,"title":["Use of fluorquinolones is associated with a reduced risk of coronary heart disease in diabetes mellitus type 2 patients"],"prefix":"10.1093","volume":"23","author":[{"given":"J","family":"Erkens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","container-title":["European Heart Journal"],"original-title":[],"link":[{"URL":"http:\/\/academic.oup.com\/eurheartj\/article-pdf\/23\/20\/1575\/17885321\/1575.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T09:44:15Z","timestamp":1503481455000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-lookup\/doi\/10.1053\/euhj.2002.3173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10,15]]},"references-count":0,"journal-issue":{"issue":"20"},"alternative-id":["S0195-668X(02)93173-8"],"URL":"https:\/\/doi.org\/10.1053\/euhj.2002.3173","relation":{},"ISSN":["0195-668X"],"issn-type":[{"value":"0195-668X","type":"print"}],"subject":[],"published":{"date-parts":[[2002,10,15]]}}}